2014
DOI: 10.3109/15563650.2014.994065
|View full text |Cite
|
Sign up to set email alerts
|

Discrepancies in reported US pricing information for digoxin-Fab

Abstract: to US $ 2,370 per 40 mg vial, three times higher than the cost of digoxin-Fab reported by Chan and Buckley. 2 This most recent increase in AWP of DigiFab ® may call into question whether digoxin-Fab continues to be cost-effective with current dosing recommendations. AWP serves as a benchmark for reimbursement in the United States; however, the cost may vary depending on wholesaler contracts or manufacturer rebates. Ultimate cost to the patient is often higher. We agree that further studies are needed to dete… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Accordingly, from our findings together with the high price 31 and limited availability of the antidote, the specific antidote (DsFab) should be considered as antidote therapy and administered appropriately and early in severe cases (life-threatening dysrhythmia, hyperkalemia, or hemodynamic instability). However, the antidote might not be required in all instances of toad poisoning, especially for ingesting the animal itself rather than the processed or dried toxin.…”
Section: Discussionmentioning
confidence: 97%
“…Accordingly, from our findings together with the high price 31 and limited availability of the antidote, the specific antidote (DsFab) should be considered as antidote therapy and administered appropriately and early in severe cases (life-threatening dysrhythmia, hyperkalemia, or hemodynamic instability). However, the antidote might not be required in all instances of toad poisoning, especially for ingesting the animal itself rather than the processed or dried toxin.…”
Section: Discussionmentioning
confidence: 97%